Dignitana - Part of the Paxman Group

Dignitana is a Swedish medical technology company focused on developing and marketing the DigniCap Scalp Cooling System. This patented device is designed to minimize hair loss in cancer patients undergoing chemotherapy. Dignitana is publicly traded on the Nasdaq First North Growth Market and is headquartered in Lund, Sweden, with operational bases in Dallas, Texas, and Milan, Italy. The DigniCap Scalp Cooling System is clinically proven and FDA-cleared, making it the first scalp cooling system approved in the United States. It provides continuous cooling during chemotherapy, helping to reduce hair loss, which can significantly improve patients' well-being and quality of life. The system is effective for patients receiving chemotherapy for various solid tumors, including breast, prostate, ovarian, uterus, and lung cancers. Dignitana aims to enhance the quality of life for cancer patients by offering accessible and affordable scalp cooling technology. In 2025, Dignitana was acquired by Paxman, furthering its mission to expand access to scalp cooling for cancer patients globally.

• Employees 24
• Founded 1996